tetano
Editor, Senior Moderator
BMC Public Health. 2019 Dec 18;19(1):1698. doi: 10.1186/s12889-019-8044-y. [h=1]Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting.[/h]
Ecarnot F[SUP]1,[/SUP][SUP]2[/SUP], Crepaldi G[SUP]3[/SUP], Juvin P[SUP]4[/SUP], Grabenstein J[SUP]5[/SUP], Del Giudice G[SUP]6[/SUP], Tan L[SUP]7[/SUP], O'Dwyer S[SUP]8[/SUP], Esposito S[SUP]9[/SUP], Bosch X[SUP]10[/SUP], Gavazzi G[SUP]11[/SUP], Papastergiou J[SUP]12[/SUP], Gaillat J[SUP]13[/SUP], Johnson R[SUP]14[/SUP], Fonzo M[SUP]15[/SUP], Rossanese A[SUP]16[/SUP], Suitner C[SUP]17[/SUP], Barratt J[SUP]18[/SUP], di Pasquale A[SUP]19[/SUP], Maggi S[SUP]20[/SUP], Michel JP[SUP]21[/SUP].
[h=3]Author information[/h] 1 EA3920, University of Franche-Comt?, Besancon, France. Fiona.ecarnot@Univ-fcomte.fr. 2 Department of Cardiology, University Hospital Jean Minjoz, Boulevard Fleming, 25000, Besancon, France. Fiona.ecarnot@Univ-fcomte.fr. 3 University of Padua, Padua, Italy. 4 Global Product Quality Management, Sanofi Pasteur, Lyon, France. 5 Executive Director, Global Vaccines Medical Affairs, Merck Research Laboratories, North Wales, PA 19454, USA. 6 Translational Science Leader, R&D Center Italy, GSK Vaccines Srl, 53100, Siena, Italy. 7 Chief Strategy Officer, Immunization Action Coalition, United States; Co-Chair, National Adult and Influenza Immunization Summit, Saint Paul, MN, USA. 8 Boots Retail (Ireland) Limited, Nangor Road, Clondalkin, Dublin, 12, Ireland. 9 Pediatric Clinic, Department of Biomedical and Surgical Sciences, Universit? degli Studi di Perugia, Perugia, Italy. 10 Catalan Institute of Oncology, Cancer Epidemiology Research Program, L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain. 11 University of Grenoble-Alpes, GREPI, FRE 3405 CNRS and University Clinic of Geriatric Medicine, University hospital of Grenoble, Grenoble, France. 12 Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada. 13 Centre Hospitalier Annecy-Genevois, Annecy, France. 14 Hon. Senior Research Fellow, Faculty of Health Sciences: Emeritus Consultant in Pain Medicine, University of Bristol, Bristol, UK. 15 DCTV - Department of Cardiac, Thoracic and Vascular Sciences, Hygiene and Public Health Unit, University of Padua, Padua, Italy. 16 Centre for Tropical Diseases, "Sacro Cuore - Don Calabria" Hospital, Negrar, Verona, Italy. 17 Department of Developmental and Social Psychology, University of Padova, Padova, Italy. 18 International Federation on Ageing, Toronto, Ontario, Canada. 19 GSK, Wavre, Belgium. 20 CNR, Institute of Neuroscience - Aging Branch, Padua, Italy. 21 University of Geneva, Geneva, Switzerland.
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Despite the existence of efficacious vaccines, the burden of vaccine-preventable diseases remains high and the potential health benefits of paediatric, adolescent and adult vaccination are not being achieved due to suboptimal vaccine coverage rates. Based on emerging evidence that pharmacy-based vaccine interventions are feasible and effective, the European Interdisciplinary Council for Ageing (EICA) brought together stakeholders from the medical and pharmacy professions, the pharmaceutical industry, patient/ageing organisations and health authorities to consider the potential for pharmacy-based interventions to increase vaccine uptake. We report here the proceedings of this 3-day meeting held in March 2018 in San Servolo island, Venice, Italy, focussing firstly on examples from countries that have introduced pharmacy-based vaccination programmes, and secondly, listing the barriers and solutions proposed by the discussion groups.
[h=4]CONCLUSIONS:[/h] A range of barriers to vaccine uptake have been identified, affecting all target groups, and in various countries and healthcare settings. Ease of accessibility is a potentially modifiable determinant in vaccine uptake, and thus, improving the diversity of settings where vaccines can be provided to adults, for example by enabling community pharmacists to vaccinate, may increase the number of available opportunities for vaccination.
[h=4]KEYWORDS:[/h] Pharmacists; Pharmacy-based interventions; Vaccination; Vaccine coverage
PMID: 31852470 DOI: 10.1186/s12889-019-8044-y
Free full text
Ecarnot F[SUP]1,[/SUP][SUP]2[/SUP], Crepaldi G[SUP]3[/SUP], Juvin P[SUP]4[/SUP], Grabenstein J[SUP]5[/SUP], Del Giudice G[SUP]6[/SUP], Tan L[SUP]7[/SUP], O'Dwyer S[SUP]8[/SUP], Esposito S[SUP]9[/SUP], Bosch X[SUP]10[/SUP], Gavazzi G[SUP]11[/SUP], Papastergiou J[SUP]12[/SUP], Gaillat J[SUP]13[/SUP], Johnson R[SUP]14[/SUP], Fonzo M[SUP]15[/SUP], Rossanese A[SUP]16[/SUP], Suitner C[SUP]17[/SUP], Barratt J[SUP]18[/SUP], di Pasquale A[SUP]19[/SUP], Maggi S[SUP]20[/SUP], Michel JP[SUP]21[/SUP].
[h=3]Author information[/h] 1 EA3920, University of Franche-Comt?, Besancon, France. Fiona.ecarnot@Univ-fcomte.fr. 2 Department of Cardiology, University Hospital Jean Minjoz, Boulevard Fleming, 25000, Besancon, France. Fiona.ecarnot@Univ-fcomte.fr. 3 University of Padua, Padua, Italy. 4 Global Product Quality Management, Sanofi Pasteur, Lyon, France. 5 Executive Director, Global Vaccines Medical Affairs, Merck Research Laboratories, North Wales, PA 19454, USA. 6 Translational Science Leader, R&D Center Italy, GSK Vaccines Srl, 53100, Siena, Italy. 7 Chief Strategy Officer, Immunization Action Coalition, United States; Co-Chair, National Adult and Influenza Immunization Summit, Saint Paul, MN, USA. 8 Boots Retail (Ireland) Limited, Nangor Road, Clondalkin, Dublin, 12, Ireland. 9 Pediatric Clinic, Department of Biomedical and Surgical Sciences, Universit? degli Studi di Perugia, Perugia, Italy. 10 Catalan Institute of Oncology, Cancer Epidemiology Research Program, L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain. 11 University of Grenoble-Alpes, GREPI, FRE 3405 CNRS and University Clinic of Geriatric Medicine, University hospital of Grenoble, Grenoble, France. 12 Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada. 13 Centre Hospitalier Annecy-Genevois, Annecy, France. 14 Hon. Senior Research Fellow, Faculty of Health Sciences: Emeritus Consultant in Pain Medicine, University of Bristol, Bristol, UK. 15 DCTV - Department of Cardiac, Thoracic and Vascular Sciences, Hygiene and Public Health Unit, University of Padua, Padua, Italy. 16 Centre for Tropical Diseases, "Sacro Cuore - Don Calabria" Hospital, Negrar, Verona, Italy. 17 Department of Developmental and Social Psychology, University of Padova, Padova, Italy. 18 International Federation on Ageing, Toronto, Ontario, Canada. 19 GSK, Wavre, Belgium. 20 CNR, Institute of Neuroscience - Aging Branch, Padua, Italy. 21 University of Geneva, Geneva, Switzerland.
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Despite the existence of efficacious vaccines, the burden of vaccine-preventable diseases remains high and the potential health benefits of paediatric, adolescent and adult vaccination are not being achieved due to suboptimal vaccine coverage rates. Based on emerging evidence that pharmacy-based vaccine interventions are feasible and effective, the European Interdisciplinary Council for Ageing (EICA) brought together stakeholders from the medical and pharmacy professions, the pharmaceutical industry, patient/ageing organisations and health authorities to consider the potential for pharmacy-based interventions to increase vaccine uptake. We report here the proceedings of this 3-day meeting held in March 2018 in San Servolo island, Venice, Italy, focussing firstly on examples from countries that have introduced pharmacy-based vaccination programmes, and secondly, listing the barriers and solutions proposed by the discussion groups.
[h=4]CONCLUSIONS:[/h] A range of barriers to vaccine uptake have been identified, affecting all target groups, and in various countries and healthcare settings. Ease of accessibility is a potentially modifiable determinant in vaccine uptake, and thus, improving the diversity of settings where vaccines can be provided to adults, for example by enabling community pharmacists to vaccinate, may increase the number of available opportunities for vaccination.
[h=4]KEYWORDS:[/h] Pharmacists; Pharmacy-based interventions; Vaccination; Vaccine coverage
PMID: 31852470 DOI: 10.1186/s12889-019-8044-y
Free full text